BioNTech SE (BNTX)
NASDAQ: BNTX · Real-Time Price · USD
112.78
+1.78 (1.60%)
At close: Aug 13, 2025, 4:00 PM
113.50
+0.72 (0.64%)
After-hours: Aug 13, 2025, 7:45 PM EDT
BioNTech SE Revenue
BioNTech SE had revenue of 260.80M EUR in the quarter ending June 30, 2025, with 102.64% growth. This brings the company's revenue in the last twelve months to 2.88B, up 6.98% year-over-year. In the year 2024, BioNTech SE had annual revenue of 2.75B, down -27.96%.
Revenue (ttm)
2.88B EUR
Revenue Growth
+6.98%
P/S Ratio
8.03
Revenue / Employee
425,044 EUR
Employees
6,772
Market Cap
27.11B USD
Revenue Chart
* This company reports financials in EUR.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 2.75B | -1.07B | -27.96% |
| Dec 31, 2023 | 3.82B | -13.49B | -77.94% |
| Dec 31, 2022 | 17.31B | -1.67B | -8.78% |
| Dec 31, 2021 | 18.98B | 18.49B | 3,834.63% |
| Dec 31, 2020 | 482.30M | 373.70M | 344.11% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 422.82B |
| Johnson & Johnson | 90.63B |
| Merck & Co. | 63.62B |
| AbbVie | 58.33B |
| AstraZeneca | 56.50B |
| Novartis AG | 55.19B |
| Eli Lilly and Company | 53.26B |
| Novo Nordisk | 49.11B |
BNTX News
- 6 days ago - CureVac settles patent dispute litigation with Pfizer and BioNTech - Reuters
- 8 days ago - These Analysts Revise Their Forecasts On BioNTech After Q2 Results - Benzinga
- 9 days ago - BioNTech SE (BNTX) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 9 days ago - BioNTech Narrows Losses, Q2 Revenue Doubles As Vaccine Collaboration Drives Growth - Benzinga
- 9 days ago - BioNTech Stock Rises as Drug Maker Beats Earnings Expectations. - Barrons
- 9 days ago - BioNTech's Q2 revenues double on higher COVID vaccine sales - Reuters
- 9 days ago - BioNTech Announces Second Quarter 2025 Financial Results and Corporate Update - GlobeNewsWire
- 12 days ago - Pfizer and BioNTech lose appeal in London over Moderna COVID vaccine patent - Fast Company